Compare PEBO & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PEBO | INSP |
|---|---|---|
| Founded | 1902 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2005 | 2018 |
| Metric | PEBO | INSP |
|---|---|---|
| Price | $34.90 | $41.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 16 |
| Target Price | $37.33 | ★ $94.00 |
| AVG Volume (30 Days) | 144.9K | ★ 1.2M |
| Earning Date | 04-21-2026 | 05-04-2026 |
| Dividend Yield | ★ 4.94% | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | ★ 0.81 | N/A |
| Revenue | $197,000.00 | ★ $82,050,000.00 |
| Revenue This Year | $17.29 | $8.02 |
| Revenue Next Year | $2.97 | $8.11 |
| P/E Ratio | $42.93 | ★ N/A |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $27.49 | $39.61 |
| 52 Week High | $35.46 | $147.03 |
| Indicator | PEBO | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 57.11 | 36.55 |
| Support Level | $33.56 | $39.61 |
| Resistance Level | $35.46 | $44.98 |
| Average True Range (ATR) | 0.60 | 2.39 |
| MACD | 0.09 | 0.22 |
| Stochastic Oscillator | 86.27 | 36.71 |
Peoples Bancorp Inc (Marietta OH) is a financial holding company. As a community bank, it offers a complete line of banking, insurance, investment, and trust solutions through its financial subsidiaries. It offers demand deposit accounts, savings accounts, real estate mortgage loans, merchant credit card transaction processing services, corporate and personal trust services, life, health, property, and casualty insurance products, and brokerage services. The bank also offers telephone and internet-based banking through both personal computers and mobile devices.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.